Toward a comprehensive long term nicotine policy

被引:75
作者
Gray, N
Henningfield, JE
Benowitz, NL
Connolly, GN
Dresler, C
Fagerstrom, K
Jarvis, MJ
Boyle, P
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
[2] Univ Calif San Francisco, Dept Med PSychiat & Biopharmaceut Sci, San Francisco, CA 94143 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Pinney Associates Inc, Bethesda, MD USA
[6] UCL, London, England
关键词
D O I
10.1136/tc.2004.010272
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Global tobacco deaths are high and rising. Tobacco use is primarily driven by nicotine addiction. Overall tobacco control policy is relatively well agreed upon but a long term nicotine policy has been less well considered and requires further debate. Reaching consensus is important because a nicotine policy is integral to the target of reducing tobacco caused disease, and the contentious issues need to be resolved before the necessary political changes can be sought. A long term and comprehensive nicotine policy is proposed here. It envisages both reducing the attractiveness and addictiveness of existing tobacco based nicotine delivery systems as well as providing alternative sources of acceptable clean nicotine as competition for tobacco. Clean nicotine is defined as nicotine free enough of tobacco toxicants to pass regulatory approval. A three phase policy is proposed. The initial phase requires regulatory capture of cigarette and smoke constituents liberalising the market for clean nicotine; regulating all nicotine sources from the same agency; and research into nicotine absorption and the role of tobacco additives in this process. The second phase anticipates clean nicotine overtaking tobacco as the primary source of the drug ( facilitated by use of regulatory and taxation measures); simplification of tobacco products by limitation of additives which make tobacco attractive and easier to smoke ( but tobacco would still be able to provide a satisfying dose of nicotine). The third phase includes a progressive reduction in the nicotine content of cigarettes, with clean nicotine freely available to take the place of tobacco as society's main nicotine source.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
[1]  
[Anonymous], 1991, LANCET, V337, P1191
[2]  
[Anonymous], 2001, RISKS ASS SMOKING CI
[3]  
[Anonymous], 2001, WHO MON ADV KNOWL RE
[4]  
[Anonymous], 2000, NIC ADD BRIT REP TOB
[5]   Tobacco-specific nitrosamines in tobacco from US brand and non-US brand cigarettes [J].
Ashley, DL ;
Beeson, MD ;
Johnson, DR ;
McCraw, JM ;
Richter, P ;
Pirkle, JL ;
Pechacek, TF ;
Song, SQ ;
Watson, CH .
NICOTINE & TOBACCO RESEARCH, 2003, 5 (03) :323-331
[6]   Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa [J].
Ayo-Yusuf, OA ;
Swart, TJP ;
Pickworth, WB .
TOBACCO CONTROL, 2004, 13 (02) :186-189
[7]   Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy -: A status report [J].
Balfour, D ;
Benowitz, N ;
Fagerström, K ;
Kunze, M ;
Keil, U .
EUROPEAN HEART JOURNAL, 2000, 21 (06) :438-445
[8]   The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive [J].
Bates, C ;
McNeill, A ;
Jarvis, M ;
Gray, N .
TOBACCO CONTROL, 1999, 8 (02) :225-235
[9]   ESTABLISHING A NICOTINE THRESHOLD FOR ADDICTION - THE IMPLICATIONS FOR TOBACCO REGULATION [J].
BENOWITZ, NL ;
HENNINGFIELD, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) :123-125
[10]  
BENOWITZ NL, 2004, ANN M SOC NIC TOB RE